PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Combination therapy with radiation shows promise in treating glioblastoma

2021-02-09
(Press-News.org) UCLA RESEARCH ALERT

FINDINGS In a study of mice, researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new approach that combines an anti-psychotic drug, a statin used to lower high cholesterol levels, and radiation to improve the overall survival in mice with glioblastoma. Glioblastoma is one of the deadliest and most difficult-to-treat brain tumors. Researchers found the triple combination extended the median survival 4-fold compared to radiation alone.

BACKGROUND Radiation therapy is part of the standard-of-care treatment regimen for glioblastoma, often helping prolong the survival of patients. However, survival times have not improved significantly over the past two decades and attempts to improve the efficacy of radiotherapy through the use of pharmaceuticals have been hampered by the normal tissue toxicity of the drugs and the inability to penetrate the blood-brain barrier.

UCLA researchers previously reported that the first-generation dopamine receptor antagonist trifluoperazine in combination with radiation prolonged survival in mouse models of glioblastoma, but ultimately, the mice become resistant to the therapy. To help overcome this resistance, the team used quetiapine, a second-generation dopamine receptor antagonist, which not only enhanced the efficacy of radiotherapy in glioblastoma but also generated a metabolic vulnerability in the lipid homeostasis. The discovery that the combination induced the cholesterol biosynthesis pathway allowed the team to target this process with statins.

METHOD The team tested the approach using patient-derived glioblastoma lines provided by the Biospecimen and Pathology Core of the UCLA SPORE in Brain Cancer. Quetiapine was identified in a screen of dopamine receptor antagonists for their ability to prevent phenotype conversion of non-tumorigenic glioblastoma cells into radiation-induced glioma initiating cells. Atorvastatin (Lipitor) was selected because of its known ability to cross the blood-brain-barrier.

IMPACT While radiation alone prolongs survival of glioblastoma to some extent, attempts to enhance the treatment have not been successful. The results of the study provide evidence that using a dopamine receptor antagonist in combination with Atorvastatin and radiation may help extend the survival for people with glioblastoma. The combination therapy also includes FDA-approved drugs that can rapidly be translated into a clinical trial.

INFORMATION:

AUTHORS The senior author Dr. Frank Pajonk, is a professor of Radiation Oncology at the David Geffen School of Medicine at UCLA and a member of the Jonsson Cancer Center. The lead author is Dr. Kruttika Bhat, a project scientist in Pajonk's laboratory. Other authors are Mohammad Saki, Fei Cheng, Ling He, Dr. Le Zhang, Angeliki Ioannidis, David Nathanson, Jonathan Tsang, Steven Bensinger, Dr. Phioang Leia Nghiemphu, Dr. Timothy Cloughesy, Dr. Linda Liau and Dr. Harley Kornblum, all of UCLA.

JOURNAL The study was published online in the Journal of the National Cancer Institute.

FUNDING The work was funded in part by the National Cancer Institute and the National Institutes of Health's Brain Specialized Programs of Research Excellence, or SPORE, at UCLA, which helps advance work in the prevention, detection and treatment of brain tumors.



ELSE PRESS RELEASES FROM THIS DATE:

Long-term environmental damage from transportation projects in Kenya, scientists warn

Long-term environmental damage from transportation projects in Kenya, scientists warn
2021-02-09
The construction of a major railway through Kenya will have long-term environmental impacts on the area, suggesting more work needs to be done to limit the damage on future infrastructure projects, a major study reveals. The biggest impact of the Standard Gauge Railway (SGR), which runs from Mombasa to Nairobi, was pollution and contamination of soil, water and air, as well as disruption of natural processes. The research, led by the University of York and part of the Development Corridors Partnership project, also showed environmental issues as a result of breaking up large areas of habitat into smaller, more isolated patches, that may not be able to support long-term natural processes. The SGR project was given the go-ahead following the completion ...

Quantum computing enables simulations to unravel mysteries of magnetic materials

Quantum computing enables simulations to unravel mysteries of magnetic materials
2021-02-09
A multi-institutional team became the first to generate accurate results from materials science simulations on a quantum computer that can be verified with neutron scattering experiments and other practical techniques. Researchers from the Department of Energy's Oak Ridge National Laboratory; the University of Tennessee, Knoxville; Purdue University and D-Wave Systems harnessed the power of quantum annealing, a form of quantum computing, by embedding an existing model into a quantum computer. Characterizing materials has long been a hallmark of classical supercomputers, which encode information using a binary system of bits that are each assigned a value of either 0 or 1. But quantum computers -- in this case, D-Wave's 2000Q - rely on qubits, which can be valued at ...

Researchers uncover hidden hunting tactics of wolves in Minnesota's Northwoods

Researchers uncover hidden hunting tactics of wolves in Minnesotas Northwoods
2021-02-09
Wolves are arguably the most well-studied large predators in the world, yet new research shows there is still a lot to learn about their hunting tactics. Typically, wolves hunt large mammals like moose, deer, and bison in packs by outrunning, outlasting, and exhausting their prey. However, throughout the dense boreal forests in North America and Eurasia, during the summer wolves often hunt beavers by themselves. But how does a wolf catch a semi-aquatic prey that spends little time on land and never ventures far from the safety of its pond? Turns out with patience, and a lot of waiting. In a new paper published in the journal Behavioral Ecology, researchers from the University of Minnesota and the Voyageurs Wolf Project--which ...

Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks

2021-02-09
CHICAGO: Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to cure. This therapy regimen includes initial chemoradiotherapy (NACR) and surgical resection, an operation that removes the cancerous part of the organ. According to researchers, this recommended therapy is often not offered to elderly patients out of concern that they will not tolerate such an intensive treatment regimen. In a new study, they found that older patients who received the therapy had outcomes comparable with those of younger patients (under 70 years old). The single-institution study from the Ochsner Clinic Foundation and The University of ...

Reimbursing hospitals for postpartum contraception could prevent unintended pregnancies

2021-02-09
PROVIDENCE, R.I. [Brown University] -- A new study finds that providing people who have recently given birth access to long-acting reversible methods of contraception, such as intrauterine devices and contraceptive implants, could help prevent them from unintentionally falling pregnant in the following months. The study -- which analyzed the effects of a 2012 Medicaid policy implemented in South Carolina -- found that expanded access to particular forms of birth control were especially helpful in preventing unintended pregnancies among adolescents who had just given birth, giving them more control over their own futures. "The ...

Early study points to potential therapeutic avenue for a pair of rare pediatric diseases

Early study points to potential therapeutic avenue for a pair of rare pediatric diseases
2021-02-09
GRAND RAPIDS, Mich. (Feb. 9, 2021) -- Scientists have devised a new approach for detecting and potentially heading off the effects of two rare pediatric diseases before birth. The study, performed in mouse models of the diseases and published today in Cell Reports, represents an important step toward much-needed early interventions for Beckwith-Wiedemann syndrome and Silver-Russell syndrome. Both diseases result in growth-related symptoms in children and often lead to additional problems later in life, such as increased cancer risk from Beckwith-Wiedemann syndrome ...

A new modifier increases the efficiency of perovskite solar cells

A new modifier increases the efficiency of perovskite solar cells
2021-02-09
The research team of NUST MISIS has presented an improved structure of perovskite solar cells. Scientists have modified perovskite-based solar cells using MXenes -- thin two-dimensional titanium carbides with high electrical conductivity. The MXenes-based modified cells showed superior performance, with power conversion efficiency exceeding 19% (the reference demonstrated 17%) and improved stabilized power output with respect to reference devices. The results have been published in the Nano energy international scientific journal. Perovskite solar cells ...

Nitrate in maternal drinking water may impair fetal growth

2021-02-09
Women whose household drinking water contained nitrate had babies that weighed, on average, 10 grams less than babies born to mothers where household water had no detectible nitrate, according to a new study from researchers at the University of Illinois Chicago and Aarhus University. The study, which is published in the journal Environmental Health Perspectives, followed pregnant women living in Denmark. The researchers found that even low nitrate levels -- about half of the allowable level set by the U.S. Environmental Protection Agency, or EPA -- caused an adverse effect. "While ...

Vaccine confidence grows under new administration, latest CUNY SPH Survey reveals

Vaccine confidence grows under new administration, latest CUNY SPH Survey reveals
2021-02-09
Under the Biden Administration, New Yorkers' acceptance of the Covid-19 vaccine has increased significantly. In September, 55% of residents reported they would take the vaccine when it became available and this January, 64% reported they would take it. Differences in vaccine acceptance persist across racial and ethnic groups. Among Whites and Asians acceptance is 70-72%; among Blacks and Latina/os it is 57-58%. On a positive note, the largest increase in rate of acceptance was seen among Black respondents, up from 33% in September to 57% in January. These are key findings from the most recent tracking survey of public perceptions and experiences in New York City during the Covid-19 pandemic, conducted January 29-31 by the City University of New York Graduate School of ...

Color is in the eye of the beholder

Color is in the eye of the beholder
2021-02-09
The colors in a flower patch appear completely different to a bear, a honeybee, a butterfly and humans. The ability to see these colors is generated by specific properties of opsins - light-sensitive proteins in the retina of our eyes. The number of opsins expressed and the molecular structure of the receptor proteins determines the colors we see. In a paper published February 9 in Proceedings of the National Academy of Sciences a team of researchers led by Harvard University develop a novel method to express long wavelength invertebrate opsin proteins in vitro and detail the molecular structure of redshift (long-wavelength) ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Combination therapy with radiation shows promise in treating glioblastoma